BelHealth Investment Partners

What BelHealth Investment Partners does

BelHealth Investment Partners, LLC is a Fort Lauderdale, Florida-based private equity firm founded in 2011 that invests exclusively in lower middle-market healthcare companies in the United States. The firm deploys $20M-$50M of equity per platform investment into founder-owned businesses with $10M-$100M in revenue, $2M-$10M in EBITDA, and $20M-$100M in enterprise value, targeting healthcare services, products, and distribution sub-sectors with favorable reimbursement, fragmentation, and add-on consolidation potential. BelHealth manages approximately $328M in assets under management and has completed more than 50 transactions representing approximately $1B+ in portfolio value.

The firm's operating model is a classic control-buyout private equity approach: it acquires wholly-owned platform companies (examples include Beach House Center for Recovery, Care Advantage, Gemini Bio, NavaDerm Partners, Precision Diagnostics, Village Fertility Pharmacy, and Integrated Care Physicians), then drives value through operational improvements, organic growth, and add-on M&A within a stated five-year hold horizon before exiting (realized exits include Qforma sold to Veeva Systems in 2015, American Health Staffing Group in 2021, and VFP Pharmacy Group in 2024). Revenue is generated through management fees on committed/invested AUM and carried interest on realizations; pricing and fund terms are not publicly disclosed.

BelHealth is staffed by a lean team of 11-50 employees led by Founding Partner Harold S. Blue and partners Dennis Drislane, Inder Tallur, and Joseph P. Wynne (CFO/CCO), supplemented by a senior advisory board that includes Dr. Arthur Laffer, Dr. Kiran Patel, Cory Stevenson (former Thermo Fisher BioProduction President), and David Kretschmer (former Anthem CIO). The firm has completed at least two fund vintages (Fund II closed June 2015) and operates as an independent LLC with no parent company, sourcing deals primarily through professional referrals, industry events, and its portfolio network rather than broad marketing.

Name

BelHealth Investment Partners

Legal name

BelHealth Investment Partners, LLC

Website

https://belhealth.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

BelHealth Investment Partners is a Fort Lauderdale-based private equity firm founded in 2011 that invests $20M-$50M per platform into lower middle-market, founder-owned US healthcare companies across services, products, and distribution, managing approximately $328M in AUM across 50+ transactions.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity

NAICS

Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industries

Multi-Sector / Generalist Growth Equity (FSANACAO), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Healthcare private equity
• Lower middle market investing
• Growth capital partnerships
• Healthcare buyout investing
• Founder-owned acquisitions

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Others

Distribution channels1 record

Marketing channels3 records

Core offering

BelHealth Investment Partners is a healthcare-focused private equity firm that invests $20M-$50M of equity per platform in founder-owned, lower middle market healthcare companies with $10M-$100M in revenue and $2M-$10M EBITDA. The firm deploys approximately $328M in assets under management across healthcare services, products, and distribution, providing growth capital, add-on acquisition support, operational expertise, and exit planning within a 5-year horizon.

Product overview

BelHealth Investment Partners is a Fort Lauderdale-based healthcare private equity firm focused on the lower middle market. The firm provides investment management services and equity capital to founder-owned healthcare companies, deploying $20M-$50M per platform investment with an enterprise value focus of $20M-$100M and revenue of $10M-$100M. BelHealth's portfolio consists of portfolio companies across healthcare sub-sectors including behavioral health treatment (Beach House Center for Recovery), home healthcare (Care Advantage), specialty pharmacy (Village Fertility Pharmacy, Quick Care Pharmacy), clinical diagnostics (Precision Diagnostics), dermatology management (NavaDerm Partners), cell culture and bioproducts (Gemini Bio), genetic testing (General Genetics Corporation), emergency medicine services (Integrated Care Physicians), and healthcare staffing (American Health Staffing Group). The firm has approximately $328M in assets under management and has completed 50+ transactions representing approximately $1B+ in value. Investment strategy focuses on founder-owned companies with favorable reimbursement, growing sectors, and fragmented markets, with a typical 5-year hold period.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Private Equity Investment

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Beach House Behavioral HealthcoreOthers · 9 April 2026Beach House Behavioral Health, a substance abuse and mental health treatment provider and portfolio company of BelHealth, announced an in-network insurance partnership with Ambetter Health, expanding access to addiction and mental health services.
• LucetcoreOthers · 7 October 2024Beach House Behavioral Health, a BelHealth portfolio company, entered into an in-network contract with Lucet, a leading behavioral health optimization company, expanding insurance network coverage.
• Asahi Kasei Bioprocess AmericacoreStrategic or Co-development Partner · 11 April 2023GeminiBio, a BelHealth portfolio company, entered a strategic partnership with Asahi Kasei Bioprocess America to collaborate on bioprocess solutions for the life science tools space.
• AvantorcoreTechnology or Integration · 23 June 2022GeminiBio, a BelHealth portfolio company, collaborated with Avantor to bring custom hydrated solutions and cell culture media to biopharma customers, combining manufacturing and distribution capabilities.
• U.S. Government (FEMA)minorOthers · 11 June 2020GeminiBio received a federal contract award to support COVID-19 testing efforts through FEMA, providing critical supplies and services.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• HealthEdge Investment Partners: Healthcare-focused lower middle market PE firm where BelHealth Founding Partner Harold Blue previously served as Founder and Managing Partner. Same sector focus, similar check size, and overlapping deal sourcing networks make this the closest comparable peer.
• Comvest Partners: Middle-market PE firm with a healthcare vertical that has employed multiple BelHealth partners and advisors (including Harold Blue and Inder Tallur). Comparable lower middle market thesis and healthcare specialization.
• Linden Capital Partners: Healthcare-dedicated middle-market PE firm based in Chicago investing in founder-owned healthcare companies. Direct competitor for the same healthcare lower middle market deals BelHealth targets.
• Avista Capital Partners: Healthcare-focused middle-market PE firm that invests in healthcare services, products, and distribution — directly overlapping BelHealth's stated healthcare sub-sectors and target company profile.
• Arsenal Capital Partners: Specialist middle-market PE firm with a dedicated healthcare vertical investing in services and products businesses. Targets similar check sizes and founder-owned companies in healthcare.
• Galen Partners: Healthcare growth equity firm investing in later-stage healthcare services, products, and technology companies. Comparable sector focus with growth-stage rather than buyout orientation.

Broad incumbents

• Welsh, Carson, Anderson & Stowe: Large healthcare-dedicated PE firm with deep sector experience across services and products. While larger and broader than BelHealth, it competes for similar founder-owned healthcare assets at the upper end of BelHealth's range.
• TPG Capital (Healthcare): Mega-fund with a dedicated healthcare vertical that increasingly writes smaller checks to access lower middle market healthcare deals. Represents the upper bound of competitive pressure on BelHealth's deal sourcing.

Regional players

• NewSpring Capital: Mid-Atlantic-focused growth equity firm with a healthcare vertical. Comparable founder-owned healthcare focus but regionally concentrated, providing partial overlap rather than direct competition for national deals.

Emerging players

• BroadOak Capital Partners: Healthcare-focused investment bank and private capital provider that has co-invested alongside BelHealth (providing financing to GeminiBio). Adjacent participant in the same healthcare lower middle market ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/belhealth-investment-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BelHealth Investment Partners